Esperion Therapeutics ESPR Preferred Stock, Shares Outstanding
Preferred Stock, Shares Outstanding at other companies
Other financials
Where this comes from
Reported directly by Esperion Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.
The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Esperion Therapeutics's preferred stock, shares outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Esperion Therapeutics's preferred stock, shares outstanding?
- Esperion Therapeutics (ESPR) reported preferred stock, shares outstanding of $0 in Q1 2026.